Paul Barriere
Advanced in Ovarian Hyperstimulation Syndrome

Paul Barriere

Nantes, FR 
Advanced in Ovarian Hyperstimulation Syndrome
Nantes, FR 
OverviewLocationsClinical Research

Overview

Paul Barriere practices in Nantes, France. Mr. Barriere is rated as an Advanced expert by MediFind in the treatment of Ovarian Hyperstimulation Syndrome. His top areas of expertise are Infertility, Ovarian Hyperstimulation Syndrome, Amenorrhea, and Ovarian Cysts.

His clinical research consists of co-authoring 78 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles and participated in 1 clinical trial in the study of Ovarian Hyperstimulation Syndrome.

Gender
Male

Locations

Nantes, 44093, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

AROPE : Early Ovarian Reserve Decreased : Impact of Exposure to Persistent Endocrine Disruptors and Organic Solvents
AROPE : Early Ovarian Reserve Decreased : Impact of Exposure to Persistent Endocrine Disruptors and Organic Solvents
Enrollment Status: Completed
Publish Date: May 23, 2023
Intervention Type: Other
Study Phase: Not Applicable
Motivations and Psychological Aspects of the Gametes' Donation
Motivations and Psychological Aspects of the Gametes' Donation
Enrollment Status: Completed
Publish Date: July 16, 2019
Intervention Type: Other
Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years
Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years
Enrollment Status: Terminated
Publish Date: July 15, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)
Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)
Enrollment Status: Terminated
Publish Date: June 16, 2017
Intervention Type: Dietary supplement, Other
Study Phase: Phase 4
View 3 Less Clinical Trials

78 Total Publications

Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France".
Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France".
Journal: European journal of obstetrics & gynecology and reproductive biology: X
Published: July 04, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Barriere's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile